​

Funding Round

Series B - Acticor Biotech

Series B - Acticor Biotech

Investment Firm

Overview

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Announced Date

Nov 06, 2019

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

GO CAPITAL

GO CAPITAL

GO CAPITAL is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorMirae Asset
Participant InvestorGO CAPITAL
Participant InvestorAnaxago
Participant InvestorKarista

Round Details and Background

Acticor Biotech raised $7749106 on 2019-11-06 in Series B

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 09, 2023
Post-IPO Equity - Acticor Biotech
1-12.9M
Mar 15, 2024
Post-IPO Equity - Acticor Biotech
4-8.7M
Feb 07, 2017
Venture Round - Acticor Biotech
1-1.6M
Jul 11, 2016
Venture Round - Acticor Biotech
2-1.5M

Recent Activity

There is no recent news or activity for this profile.